Levothyroxine Accord-Uk

Levothyroxine, the active ingredient in Levothyroxine Accord-Uk, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient thyroid hormone in patients with hypothyroidism. GNH USA supplies Levothyroxine Accord-Uk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levothyroxine acts on the thyroid hormone pathway to restore normal metabolic function. - Hypothyroidism: normalizes thyroid hormone levels and alleviates fatigue, weight gain, and cold intolerance. - Thyroid hormone replacement therapy: provides a stable source of T4 for patients after thyroidectomy or radioactive iodine treatment. - Goiter: reduces gland size by correcting hormonal deficiency that stimulates thyroid growth.

Levothyroxine may cause a range of adverse reactions, most of which are dose‑related and reversible upon adjustment.

Common Side Effects: - Headache: mild to moderate discomfort often occurring early in therapy. - Nervousness: feelings of anxiety or restlessness. - Insomnia: difficulty falling or staying asleep. - Weight loss: unintended reduction in body weight. - Palpitations: sensation of rapid or irregular heartbeat. - Heat intolerance: increased sensitivity to warm environments.

Serious or Rare Side Effects: - Chest pain: may indicate cardiac strain. - Severe tachycardia: excessively fast heart rate requiring medical attention. - Arrhythmia: irregular heart rhythm. - Bone loss (osteoporosis): long‑term excess hormone exposure. - Allergic reaction (rash, swelling, breathing difficulty): signs of hypersensitivity. - Myocardial infarction: rare but possible in susceptible individuals.

Levothyroxine requires careful monitoring and individualized dosing to avoid over‑ or under‑replacement. - Dose titration: adjust based on serial TSH and free T4 measurements. - Cardiovascular disease: monitor heart rate and rhythm, especially in patients with coronary artery disease. - Elderly patients: initiate therapy at lower doses to reduce risk of cardiac events. - Pregnancy: use only when the expected benefit justifies potential risk to the fetus. - Drug monitoring: regular thyroid function tests are essential for safe long‑term use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levothyroxine absorption and metabolism can be altered by several concomitant medicines.

Major Interactions (Avoid): - Calcium supplements: reduce levothyroxine absorption when taken together. - Iron salts: decrease bioavailability if administered within the same hour. - Antacids containing aluminum or magnesium: interfere with gastrointestinal uptake. - Amiodarone: may cause unpredictable changes in thyroid hormone levels. - Warfarin: levothyroxine can enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hyperthyroidism. - Corticosteroids: increase hormone metabolism, potentially lowering efficacy. - Phenobarbital and phenytoin: induce hepatic enzymes, increasing clearance. - Cholestyramine: binds levothyroxine and reduces absorption. - Rifampin: decreases serum levothyroxine concentrations, possibly necessitating dose adjustment.